Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Efficacy and Safety of Ularitide for the Treatment of Acute Decompensated Heart Failure

ClinicalTrials.gov ID: NCT01661634

Public ClinicalTrials.gov record NCT01661634. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 11:22 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of Ularitide (Urodilatin) Intravenous Infusion in Patients Suffering From Acute Decompensated Heart Failure [TRUE-AHF]

Study identification

NCT ID
NCT01661634
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Cardiorentis
Industry
Enrollment
2,157 participants

Conditions and interventions

Interventions

  • Ularitide Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 85 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 30, 2012
Primary completion
Oct 31, 2015
Completion
Feb 29, 2016
Last update posted
Oct 22, 2018

2012 – 2016

United States locations

U.S. sites
39
U.S. states
23
U.S. cities
37
Facility City State ZIP Site status
Not listed Huntsville Alabama 35801
Not listed Montgomery Alabama 36106
Not listed Sacramento California 95817
Not listed Littleton Colorado 80120
Not listed Trumbull Connecticut 06611
Not listed Washington D.C. District of Columbia 20422
Not listed Jacksonville Florida 32216
Not listed Lawrenceville Georgia 30046
Not listed Peoria Illinois 61606
Not listed Rockford Illinois 61107
Not listed Kansas City Kansas 66160
Not listed Alexandria Louisiana 71303
Not listed Worcester Massachusetts 01655
Not listed Detroit Michigan 48201
Not listed Detroit Michigan 48202
Not listed Detroit Michigan 48235
Not listed Royal Oak Michigan 48073
Not listed Minneapolis Minnesota 55415
Not listed St Louis Missouri 63110
Not listed Lincoln Nebraska 68526
Not listed Newark New Jersey 07107
Not listed Brooklyn New York 11203
Not listed The Bronx New York 10467
Not listed Cincinnati Ohio 45219
Not listed Columbus Ohio 43210
Not listed Middletown Ohio 45005
Not listed Toledo Ohio 43614
Not listed Philadelphia Pennsylvania 19141
Not listed Charleston South Carolina 29425
Not listed Chattanooga Tennessee 37403
Not listed Nashville Tennessee 37232
Not listed Austin Texas 78758
Not listed Dallas Texas 75390
Not listed Fort Worth Texas 76104
Not listed Houston Texas 77030
Not listed Charlottesville Virginia 22908
Not listed Midlothian Virginia 23114
Not listed Norfolk Virginia 23507
Not listed Salem Virginia 24153

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 124 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01661634, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 22, 2018 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01661634 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →